| Document |
Document Title |
|
JPS50101358A |
1498132 Steroid [16α,17-b]dioxanes E R SQUIBB & SONS Inc 15 Jan 1975 [16 Jan 1974] 1776/75 Headings C2U and C2C The invention comprises 3,20-dioxo pregnenes having an 11#-hydroxy or 11-oxo group and having at position 16,17 a fused-on 1...
|
|
JPS5096559A |
1461663 Preparing 17-esters of 17α,21-dihydroxy steroids LARK SpA 12 Nov 1974 [4 Jan 1974 (2)] 27543/74 Heading C2U A 17 - monoester of a 17α,21 - dihydroxy steroid is prepared by esterifying the corresponding 17α,21-dihydroxy steroid...
|
|
JPS5096558A |
1461663 Preparing 17-esters of 17α,21-dihydroxy steroids LARK SpA 12 Nov 1974 [4 Jan 1974 (2)] 27543/74 Heading C2U A 17 - monoester of a 17α,21 - dihydroxy steroid is prepared by esterifying the corresponding 17α,21-dihydroxy steroid...
|
|
JPS5069060A |
15 alpha -Sulfonyl-12 beta -hydroxypregnanes of the formula WHEREIN Ac is lower-acyl and R is alkyl, cycloalkyl, aralkyl or aryl, which are useful as intermediates for the production of digoxigenin, are produced by the selective sulfonic...
|
|
JPS5069061A |
20-Cyano-17 alpha -H steroids having as the 17-position substituent the group COOR ¦ CHCN ¦ wherein R is H, alkyl of 1-8 carbon atoms or benzyl, having a 13-methyl or 13-ethyl group and which are unsubstituted or substituted with an al...
|
|
JPS5011911B1 |
1,267,915. #1,3,5(10)-Steroids. GLAXO LABORATORIES Ltd. 23 May, 1969 [24 May, 1968], No. 25005/68. Heading C2U. The invention comprises #1,3,5(10)-steroids having either an etherified hydroxyl group in the 3-position and a formyl or carb...
|
|
JPS5049269A |
|
|
JPS49132064A |
The present invention relates to new conjugates of glycine and taurine with compounds of the fusidic acid series according to formulae I and II below, to methods for the preparation of such compounds, and to pharmaceutical compositions t...
|
|
JPS4994657A |
Novel dimeric and monomeric selenium-75 derivatives of steroids are made by reacting a keto steroid with selenium-75 dioxide or selenious acid-Se75. The resulting diselenide dimers can be converted into monomeric compounds by the use of ...
|
|
JPS4986358A |
1417808 7α-cyano and 7α-carboxy steroids G D SEARLE & CO 19 Nov 1973 [1 Dec 1972] 53632/73 Heading C2U Novel steroids of the formulµ (wherein #1 is optional; R is CH 3 or, when #1 is absent, it may also be H; and Z is H, an alkali met...
|
|
JPS4976856A |
|
|
JPS4920772B1 |
1,274,367. Steroid compositions and treatments. G. D. SEARLE & CO. 15 June, 1970 [16 June, 1969], No. 28837/70. Headings A5B and A5E. [Also in Division C2] Chemosterilant steroids of the formula wherein R and R1 are C 1-7 alkyl; n is 4 o...
|
|
JPS4925116A |
|
|
JPS4925117A |
|
|
JPS499462B1 |
3-Cyclopentylethers of gonatrienes and gonate-traenes of general formula (I): R1=polycarbonalkyl (C2-8) or apart from when X=1a- also methyl; Z=carbonyl or hydroxymethylene; R=alkyl (C1-8), ethynyl or chloroethynyl; R2=alkanoyloxy (C1-8)...
|
|
JPS49256A |
androsteronephosphate of formula (I): (I) has hypocholesterolaemic activity and may be used in the treatment of hypocholesterolaemia as well as in the treatment or prevention of atheromatosis, coronary insufficiency and arteriasis of the...
|
|
JPS4838701B1 |
This invention is concerned with novel 21-phosphate esters of 17 alpha -acyloxy-21-hydroxy steroids of the pregane series and with methods of preparing such compounds. The compounds are useful as topical anti-inflamatory agents.
|
